A detailed history of Jones Financial Companies Lllp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Jones Financial Companies Lllp holds 186 shares of NBIX stock, worth $21,176. This represents 0.0% of its overall portfolio holdings.

Number of Shares
186
Previous 131 41.98%
Holding current value
$21,176
Previous $15,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025

BUY
$111.62 - $139.44 $6,139 - $7,669
55 Added 41.98%
186 $25,000
Q3 2024

Nov 12, 2024

BUY
$114.58 - $153.15 $12,260 - $16,387
107 Added 445.83%
131 $15,000
Q2 2024

Aug 14, 2024

BUY
$130.86 - $143.19 $3,140 - $3,436
24 New
24 $3,000
Q2 2022

Aug 08, 2022

BUY
$75.79 - $100.07 $985 - $1,300
13 New
13 $1,000
Q2 2021

Aug 12, 2021

SELL
$89.43 - $102.27 $536 - $613
-6 Closed
0 $0
Q1 2021

Apr 30, 2021

BUY
$87.57 - $119.4 $525 - $716
6 New
6 $1,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $10.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Jones Financial Companies Lllp Portfolio

Follow Jones Financial Companies Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.